Subsequently, the doxorubicin prodrug was cleaved by caspase-3 to release the antitumor drug doxorubicin, which induces tumor immunogenic death, significantly increases the levels of antigens and damage-related pattern molecules, and promotes lymphocyte infiltration into the tumor. Here, CASP3 is linked to neoplasm.